MindMaze Therapeutics Holding (RLFTF)

[aGuyUS]

The IV Clinical trial masking states Quadruple

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 144 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Multicenter trial, initially conducted at a single center with a safety/futility assessment following enrollment of 30 patients
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description: Randomized, placebo-controlled trial with identical drug and placebo infusion bags
Primary Purpose: Treatment
Official Title: Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
Actual Study Start Date : May 15, 2020
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : September 2020